Bond Analysis of Titanium Rods Embedded in Masonry

Among the techniques utilized for strengthening masonry structures with advanced materials, the adoption of near-surface mounted (NSM) titanium rods stands out as a promising method for increasing the flexural and shear strength of masonry structures. This method is also known as Bed Joint Reinforcement. Ensuring an effective performance of this technique hinges on establishing a strong bond between the NSM reinforcement and the substrate masonry material. The primary objective of this project was to study the mechanics of this bond using NSM threaded and smooth titanium rods while scrutinizing the impact of key parameters on bond performance. Variables under investigation encompassed the rod type (smooth and threaded), bond length, and the material used to fill the groove (type of mortars). It was found that threaded rods outperformed all other types investigated, and pull-out strengths can be significantly improved through careful selection and optimization of the mortar type and bond length.

A Review of the Use of Titanium for Reinforcement of Masonry Structures

Titanium has exceptional durability, very high specific strength, a thermal expansion coefficient similar to construction materials, low weight density, and its cost has drastically decreased over the last decades. One of the main requirements in conservation engineering is the durability of the retrofit materials and the reversibility of interventions, and a possible interesting solution is the use of titanium alloys coupled with inorganic matrices made of low-cement or lime mortars. Titanium has recently been used to reinforce important masonry and archeological monuments, but little is known about this. Its use is increasing in conservation engineering without adequate knowledge of its characteristics, grades, and properties. This paper summarizes the main features of titanium alloys, its recent applications, and discusses its drawbacks and advantages compared to other retrofit materials and methods. It is demonstrated that titanium alloys can be effectively used in many applications to reinforce masonry structures while complying with requirements in terms of durability, compatibility, and reversibility. Given its mechanical properties, its use in the repair and reinforcement of masonry structures could be particularly interesting in seismically prone areas.

Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity

BACKGROUND

Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterised by hypotonia, ataxia, cognitive impairment, abnormal eye movements, respiratory control disturbances and a distinctive mid-hindbrain malformation. JS demonstrates substantial phenotypic variability and genetic heterogeneity. This study provides a comprehensive view of the current genetic basis, phenotypic range and gene-phenotype associations in JS.

METHODS

We sequenced 27 JS-associated genes in 440 affected individuals (375 families) from a cohort of 532 individuals (440 families) with JS, using molecular inversion probe-based targeted capture and next-generation sequencing. Variant pathogenicity was defined using the Combined Annotation Dependent Depletion algorithm with an optimised score cut-off.

RESULTS

We identified presumed causal variants in 62% of pedigrees, including the first B9D2 mutations associated with JS. 253 different mutations in 23 genes highlight the extreme genetic heterogeneity of JS. Phenotypic analysis revealed that only 34% of individuals have a 'pure JS' phenotype. Retinal disease is present in 30% of individuals, renal disease in 25%, coloboma in 17%, polydactyly in 15%, liver fibrosis in 14% and encephalocele in 8%. Loss of CEP290 function is associated with retinal dystrophy, while loss of TMEM67 function is associated with liver fibrosis and coloboma, but we observe no clear-cut distinction between JS subtypes.

CONCLUSIONS

This work illustrates how combining advanced sequencing techniques with phenotypic data addresses extreme genetic heterogeneity to provide diagnostic and carrier testing, guide medical monitoring for progressive complications, facilitate interpretation of genome-wide sequencing results in individuals with a variety of phenotypes and enable gene-specific treatments in the future.

Adenoid cystic carcinoma developing in the nasal orbit

PURPOSE

To describe the clinical, imaging, and histopathologic findings of an adenoid cystic carcinoma that occurred in the medial orbit.

METHODS

A 26-year-old man developed a painless soft tissue mass in the nasal aspect of the left orbit. Computed tomography was done, and incisional biopsy performed elsewhere disclosed adenoid cystic carcinoma. Orbital exenteration was performed.

RESULTS

Computed tomography showed a 1.5cm mass in the antronasal region of the orbit without bone erosion. Histopathology disclosed adenoid cystic carcinoma.

CONCLUSIONS

Although orbital adenoid cystic carcinoma usually originates superotemporally in the main lacrimal gland, it can develop in the nasal orbit, possibly from ectopic lacrimal gland tissue. Adenoid cystic carcinoma should be included in the differential diagnosis of tumors of the nasal orbit.

Results of treatment of malignant germ cell tumors in 93 children: a report from the Childrens Cancer Study Group

We report treatment results in 93 children entered on study from 1978 to 1984 with malignant germ cell tumors (MGCTs), excluding dysgerminoma and tumors of the testis or brain. The estimated 4-year survival and event-free survival (EFS) for all 93 patients were 54% and 49%, respectively. For 30 children with ovarian tumors, the estimated 4-year survival was 67% and EFS was 63%. For 63 children with nongonadal tumors, survival and EFS were 48% and 42%, respectively. The comparison of EFS between ovarian and nongonadal tumors was significant at P = .03. The treatment plan included a second-look surgical procedure after 18 weeks of chemotherapy. Over half of 36 patients evaluated as having a residual mass present immediately before second-look surgery had no malignant tumor after review of surgical specimens. Age greater than 11 years at diagnosis, incomplete removal of tumor at first surgery, and more than one structure or organ involved at diagnosis increased the risk for adverse event. The histologic subtype of the primary tumor was not related to outcome. Diagnosis was verified by independent pathologic review, and treatment was uniform. Seventeen percent of all registered patients (21 of 127) were excluded because of ineligible pathologic diagnoses; sixty percent (13 of 21) were immature teratomas.

Effects of beta-carotene and retinyl palmitate on corn oil-induced superoxide dismutase and catalase in rats

The present study was undertaken to determine the effects of beta-carotene on corn oil-induced superoxide dismutase and catalase. Six groups of male Buffalo rats were fed the following diets for 6 wk: a control diet containing recommended levels of beta-carotene and retinyl palmitate, a retinol diet containing 10 times the recommended level of retinyl palmitate, and a beta-carotene diet containing 10 times the recommended levels of beta-carotene and adequate levels of retinyl palmitate. Each vitamin combination was fed with either 5% (wt/wt) corn oil (low fat) or 20% corn oil (high fat). Plasma total beta-carotene levels were highest in the beta-carotene groups. Levels varied inversely with the level of fat in the control group and directly with fat in the beta-carotene group. Transport of beta-carotene appeared to parallel that of cholesterol in that 36 and 35%, respectively, were associated with the low density lipoprotein fraction. Accumulation of beta-carotene in the liver was apparent from the observation that levels in liver were much higher than those in plasma. Superoxide dismutase activity was much lower in the beta-carotene groups than in the retinol groups, irrespective of level of fat, and catalase activity was also lower in the beta-carotene group, but it was in proportion to the level of fat. These findings suggest that beta-carotene functions as an antioxidant in vivo.